Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2026-01-10 @ 4:16 AM
Study NCT ID:
NCT04102020
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-20
First Post:
2019-09-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-03-26
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-06
Completion Date Type:
ESTIMATED
First Submit Date:
2019-09-23
First Submit QC Date:
None
Study First Post Date:
2019-09-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-07-29
Results First Submit QC Date:
None
Results First Post Date:
2025-08-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-08-20
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-08-19
Last Update Post Date:
2025-08-20
Last Update Post Date Type:
ACTUAL